Victor Moreno, Desamparados Roda, Joanna Pikiel, Jose Trigo, Joaquim Bosch-Barrera, Yvette Drew, Rebecca Kristeleit, Sandrine Hiret, David L Bajor, Patricia Cruz, J Thaddeus Beck, Srimoyee Ghosh, Christine Dabrowski, Grace Antony, Tao Duan, Jennifer Veneris, Eleftherios Zografos, Janakiraman Subramanian. Clin Lung Cancer 2022
Times Cited: 2
Times Cited: 2
Times Cited
Times Co-cited
Similarity
Dostarlimab in the treatment of recurrent or primary advanced endometrial cancer.
Lawrence Kasherman, Soha Ahrari, Stephanie Lheureux. Future Oncol 2021
Lawrence Kasherman, Soha Ahrari, Stephanie Lheureux. Future Oncol 2021
100
An Integrated Analysis of Dostarlimab Immunogenicity.
Sharon Lu, Ronald R Bowsher, Amanda Clancy, Amy Rosen, Mingxuan Zhang, Ying Yang, Kathleen Koeck, Minggeng Gao, Elizabeth Potocka, Wei Guo,[...]. AAPS J 2021
Sharon Lu, Ronald R Bowsher, Amanda Clancy, Amy Rosen, Mingxuan Zhang, Ying Yang, Kathleen Koeck, Minggeng Gao, Elizabeth Potocka, Wei Guo,[...]. AAPS J 2021
100
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.
Ana Oaknin, Lucy Gilbert, Anna V Tinker, Jubilee Brown, Cara Mathews, Joshua Press, Renaud Sabatier, David M O'Malley, Vanessa Samouelian, Valentina Boni,[...]. J Immunother Cancer 2022
Ana Oaknin, Lucy Gilbert, Anna V Tinker, Jubilee Brown, Cara Mathews, Joshua Press, Renaud Sabatier, David M O'Malley, Vanessa Samouelian, Valentina Boni,[...]. J Immunother Cancer 2022
100
A review of cancer immunotherapy: from the past, to the present, to the future.
K Esfahani, L Roudaia, N Buhlaiga, S V Del Rincon, N Papneja, W H Miller. Curr Oncol 2020
K Esfahani, L Roudaia, N Buhlaiga, S V Del Rincon, N Papneja, W H Miller. Curr Oncol 2020
100
Hyaluronic acid decorated tacrolimus-loaded nanoparticles: Efficient approach to maximize dermal targeting and anti-dermatitis efficacy.
Fan Zhuo, Mohammed A S Abourehab, Zahid Hussain. Carbohydr Polym 2018
Fan Zhuo, Mohammed A S Abourehab, Zahid Hussain. Carbohydr Polym 2018
50
Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care.
Sima Singh, Arshid Numan, Nikhil Agrawal, Murtaza M Tambuwala, Vijender Singh, Prashant Kesharwani. Int Immunopharmacol 2020
Sima Singh, Arshid Numan, Nikhil Agrawal, Murtaza M Tambuwala, Vijender Singh, Prashant Kesharwani. Int Immunopharmacol 2020
50
Management of locally advanced primary and recurrent rectal cancer.
Johannes H W de Wilt, Maarten Vermaas, Floris T J Ferenschild, Cornelis Verhoef. Clin Colon Rectal Surg 2007
Johannes H W de Wilt, Maarten Vermaas, Floris T J Ferenschild, Cornelis Verhoef. Clin Colon Rectal Surg 2007
50
Cancer statistics, 2022.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2022
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2022
50
Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy.
Zahid Hussain, Muhammad Abdur Rahim, Nasrullah Jan, Hassan Shah, Mutasem Rawas-Qalaji, Shahzeb Khan, Mohammad Sohail, Hnin Ei Thu, Nor Amlizan Ramli, Rai Muhammad Sarfraz,[...]. J Control Release 2021
Zahid Hussain, Muhammad Abdur Rahim, Nasrullah Jan, Hassan Shah, Mutasem Rawas-Qalaji, Shahzeb Khan, Mohammad Sohail, Hnin Ei Thu, Nor Amlizan Ramli, Rai Muhammad Sarfraz,[...]. J Control Release 2021
50
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non-small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design.
Francesco Passiglia, Paolo Bironzo, Luisella Righi, Angela Listì, Francesca Arizio, Silvia Novello, Marco Volante, Giorgio Vittorio Scagliotti. Clin Lung Cancer 2021
Francesco Passiglia, Paolo Bironzo, Luisella Righi, Angela Listì, Francesca Arizio, Silvia Novello, Marco Volante, Giorgio Vittorio Scagliotti. Clin Lung Cancer 2021
50
Self-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood-brain barrier.
Mohammed As Abourehab, Osama Aa Ahmed, Gehan F Balata, Waleed H Almalki. Int J Nanomedicine 2018
Mohammed As Abourehab, Osama Aa Ahmed, Gehan F Balata, Waleed H Almalki. Int J Nanomedicine 2018
50
Monoclonal antibodies in cancer immunotherapy.
Ilgin Kimiz-Gebologlu, Sultan Gulce-Iz, Cigir Biray-Avci. Mol Biol Rep 2018
Ilgin Kimiz-Gebologlu, Sultan Gulce-Iz, Cigir Biray-Avci. Mol Biol Rep 2018
50
A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Alex D Waldman, Jill M Fritz, Michael J Lenardo. Nat Rev Immunol 2020
Alex D Waldman, Jill M Fritz, Michael J Lenardo. Nat Rev Immunol 2020
50
Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases.
Niloufar Rahiman, Yuliya V Markina, Prashant Kesharwani, Thomas P Johnston, Amirhossein Sahebkar. J Control Release 2022
Niloufar Rahiman, Yuliya V Markina, Prashant Kesharwani, Thomas P Johnston, Amirhossein Sahebkar. J Control Release 2022
50
Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
Soumya Swaminathan, Chandrasekaran Padmapriyadarsini, Perumal Venkatesan, Gopalan Narendran, Santhanakrishnan Ramesh Kumar, Sheik Iliayas, Pradeep A Menon, Sriram Selvaraju, Navaneetha P Pooranagangadevi, Perumal K Bhavani,[...]. Clin Infect Dis 2011
Soumya Swaminathan, Chandrasekaran Padmapriyadarsini, Perumal Venkatesan, Gopalan Narendran, Santhanakrishnan Ramesh Kumar, Sheik Iliayas, Pradeep A Menon, Sriram Selvaraju, Navaneetha P Pooranagangadevi, Perumal K Bhavani,[...]. Clin Infect Dis 2011
50
Computational Identification of Druggable Bioactive Compounds from Catharanthus roseus and Avicennia marina against Colorectal Cancer by Targeting Thymidylate Synthase.
Md Rashedul Islam, Md Abdul Awal, Ahmed Khames, Mohammad A S Abourehab, Abdus Samad, Walid M I Hassan, Rahat Alam, Osman I Osman, Suza Mohammad Nur, Mohammad Habibur Rahman Molla,[...]. Molecules 2022
Md Rashedul Islam, Md Abdul Awal, Ahmed Khames, Mohammad A S Abourehab, Abdus Samad, Walid M I Hassan, Rahat Alam, Osman I Osman, Suza Mohammad Nur, Mohammad Habibur Rahman Molla,[...]. Molecules 2022
50
The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer.
Sima Singh, Arshid Numan, Balaji Maddiboyina, Saahil Arora, Yassine Riadi, Shadab Md, Nabil A Alhakamy, Prashant Kesharwani. Drug Discov Today 2021
Sima Singh, Arshid Numan, Balaji Maddiboyina, Saahil Arora, Yassine Riadi, Shadab Md, Nabil A Alhakamy, Prashant Kesharwani. Drug Discov Today 2021
50
Advances in cancer immunotherapy 2019 - latest trends.
Stephan Kruger, Matthias Ilmer, Sebastian Kobold, Bruno L Cadilha, Stefan Endres, Steffen Ormanns, Gesa Schuebbe, Bernhard W Renz, Jan G D'Haese, Hans Schloesser,[...]. J Exp Clin Cancer Res 2019
Stephan Kruger, Matthias Ilmer, Sebastian Kobold, Bruno L Cadilha, Stefan Endres, Steffen Ormanns, Gesa Schuebbe, Bernhard W Renz, Jan G D'Haese, Hans Schloesser,[...]. J Exp Clin Cancer Res 2019
50
50
Immune checkpoint inhibitors: a promising anticancer therapy.
Sima Singh, Daniel Hassan, Hibah M Aldawsari, Nagashekhara Molugulu, Rahul Shukla, Prashant Kesharwani. Drug Discov Today 2020
Sima Singh, Daniel Hassan, Hibah M Aldawsari, Nagashekhara Molugulu, Rahul Shukla, Prashant Kesharwani. Drug Discov Today 2020
50
Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial.
Ana Oaknin, Anna V Tinker, Lucy Gilbert, Vanessa Samouëlian, Cara Mathews, Jubilee Brown, Maria-Pilar Barretina-Ginesta, Victor Moreno, Adriano Gravina, Cyril Abdeddaim,[...]. JAMA Oncol 2020
Ana Oaknin, Anna V Tinker, Lucy Gilbert, Vanessa Samouëlian, Cara Mathews, Jubilee Brown, Maria-Pilar Barretina-Ginesta, Victor Moreno, Adriano Gravina, Cyril Abdeddaim,[...]. JAMA Oncol 2020
50
Identification and characterization of a novel antimicrobial peptide compound produced by Bacillus megaterium strain isolated from oral microflora.
Abdullah S A Al-Thubiani, Yahia A Maher, Adel Fathi, Mohammed A S Abourehab, Mohammed Alarjah, Mohd S A Khan, Saleh B Al-Ghamdi. Saudi Pharm J 2018
Abdullah S A Al-Thubiani, Yahia A Maher, Adel Fathi, Mohammed A S Abourehab, Mohammed Alarjah, Mohd S A Khan, Saleh B Al-Ghamdi. Saudi Pharm J 2018
50
Design and development of novel hyaluronate-modified nanoparticles for combo-delivery of curcumin and alendronate: fabrication, characterization, and cellular and molecular evidences of enhanced bone regeneration.
Jinlei Dong, Lei Tao, Mohammed A S Abourehab, Zahid Hussain. Int J Biol Macromol 2018
Jinlei Dong, Lei Tao, Mohammed A S Abourehab, Zahid Hussain. Int J Biol Macromol 2018
50
Bilosomes in the context of oral immunization: development, challenges and opportunities.
Anshuman Shukla, Vijay Mishra, Prashant Kesharwani. Drug Discov Today 2016
Anshuman Shukla, Vijay Mishra, Prashant Kesharwani. Drug Discov Today 2016
50
Immune checkpoint inhibitors win the 2018 Nobel Prize.
Pei-Wei Huang, John Wen-Cheng Chang. Biomed J 2019
Pei-Wei Huang, John Wen-Cheng Chang. Biomed J 2019
50
Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment.
Ravi Bandaru, Smruti Rekha Rout, Omkar S Kamble, Sangram K Samal, Bapi Gorain, Amirhossein Sahebkar, Farhan J Ahmed, Prashant Kesharwani, Rambabu Dandela. Process Biochem 2022
Ravi Bandaru, Smruti Rekha Rout, Omkar S Kamble, Sangram K Samal, Bapi Gorain, Amirhossein Sahebkar, Farhan J Ahmed, Prashant Kesharwani, Rambabu Dandela. Process Biochem 2022
100
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
Andrea Cercek, Melissa Lumish, Jenna Sinopoli, Jill Weiss, Jinru Shia, Michelle Lamendola-Essel, Imane H El Dika, Neil Segal, Marina Shcherba, Ryan Sugarman,[...]. N Engl J Med 2022
Andrea Cercek, Melissa Lumish, Jenna Sinopoli, Jill Weiss, Jinru Shia, Michelle Lamendola-Essel, Imane H El Dika, Neil Segal, Marina Shcherba, Ryan Sugarman,[...]. N Engl J Med 2022
50
Dostarlimab for the treatment of advanced endometrial cancer.
Andres Redondo, Alejandro Gallego, Marta Mendiola. Expert Rev Clin Pharmacol 2022
Andres Redondo, Alejandro Gallego, Marta Mendiola. Expert Rev Clin Pharmacol 2022
50
50
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.
Tim Wartewig, Zsuzsanna Kurgyis, Selina Keppler, Konstanze Pechloff, Erik Hameister, Rupert Öllinger, Roman Maresch, Thorsten Buch, Katja Steiger, Christof Winter,[...]. Nature 2017
Tim Wartewig, Zsuzsanna Kurgyis, Selina Keppler, Konstanze Pechloff, Erik Hameister, Rupert Öllinger, Roman Maresch, Thorsten Buch, Katja Steiger, Christof Winter,[...]. Nature 2017
50
Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
Keisuke Okudaira, Ryota Hokari, Yoshikazu Tsuzuki, Yoshikiyo Okada, Shunsuke Komoto, Chikako Watanabe, Chie Kurihara, Atsushi Kawaguchi, Shigeaki Nagao, Miyuki Azuma,[...]. Int J Oncol 2009
Keisuke Okudaira, Ryota Hokari, Yoshikazu Tsuzuki, Yoshikiyo Okada, Shunsuke Komoto, Chikako Watanabe, Chie Kurihara, Atsushi Kawaguchi, Shigeaki Nagao, Miyuki Azuma,[...]. Int J Oncol 2009
50
Characterization of spatial distribution of tumor-infiltrating CD8+ T cells refines their prognostic utility for pancreatic cancer survival.
Yohei Masugi, Tokiya Abe, Akihisa Ueno, Yoko Fujii-Nishimura, Hidenori Ojima, Yutaka Endo, Yusuke Fujita, Minoru Kitago, Masahiro Shinoda, Yuko Kitagawa,[...]. Mod Pathol 2019
Yohei Masugi, Tokiya Abe, Akihisa Ueno, Yoko Fujii-Nishimura, Hidenori Ojima, Yutaka Endo, Yusuke Fujita, Minoru Kitago, Masahiro Shinoda, Yuko Kitagawa,[...]. Mod Pathol 2019
50
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
Benjamin G Neel, Haihua Gu, Lily Pao. Trends Biochem Sci 2003
Benjamin G Neel, Haihua Gu, Lily Pao. Trends Biochem Sci 2003
50
PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2.
Nikolaos Patsoukis, Lequn Li, Duygu Sari, Victoria Petkova, Vassiliki A Boussiotis. Mol Cell Biol 2013
Nikolaos Patsoukis, Lequn Li, Duygu Sari, Victoria Petkova, Vassiliki A Boussiotis. Mol Cell Biol 2013
50
Enhancement of antitumor immunity by CTLA-4 blockade.
D R Leach, M F Krummel, J P Allison. Science 1996
D R Leach, M F Krummel, J P Allison. Science 1996
50
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab.
Rebecca Kristeleit, Cara Mathews, Andres Redondo, Susan Boklage, Jennifer Hanlon, Ellie Im, Jubilee Brown. Int J Gynecol Cancer 2022
Rebecca Kristeleit, Cara Mathews, Andres Redondo, Susan Boklage, Jennifer Hanlon, Ellie Im, Jubilee Brown. Int J Gynecol Cancer 2022
100
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
Scott Antonia, Sarah B Goldberg, Ani Balmanoukian, Jamie E Chaft, Rachel E Sanborn, Ashok Gupta, Rajesh Narwal, Keith Steele, Yu Gu, Joyson J Karakunnel,[...]. Lancet Oncol 2016
Scott Antonia, Sarah B Goldberg, Ani Balmanoukian, Jamie E Chaft, Rachel E Sanborn, Ashok Gupta, Rajesh Narwal, Keith Steele, Yu Gu, Joyson J Karakunnel,[...]. Lancet Oncol 2016
50
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial.
Amita Patnaik, Glen J Weiss, Drew W Rasco, Lisa Blaydorn, Amy Mirabella, Murali Beeram, Wei Guo, Sharon Lu, Hadi Danaee, Kristen McEachern,[...]. Cancer Chemother Pharmacol 2022
Amita Patnaik, Glen J Weiss, Drew W Rasco, Lisa Blaydorn, Amy Mirabella, Murali Beeram, Wei Guo, Sharon Lu, Hadi Danaee, Kristen McEachern,[...]. Cancer Chemother Pharmacol 2022
50
MAPK pathway: a potential target for the treatment of non-small-cell lung carcinoma.
Rajesh Pradhan, Gautam Singhvi, Sunil Kumar Dubey, Gaurav Gupta, Kamal Dua. Future Med Chem 2019
Rajesh Pradhan, Gautam Singhvi, Sunil Kumar Dubey, Gaurav Gupta, Kamal Dua. Future Med Chem 2019
50
PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation.
Mei Ji, Yan Liu, Qing Li, Xiao-Dong Li, Wei-Qing Zhao, Hanze Zhang, Xiaofei Zhang, Jing-Ting Jiang, Chang-Ping Wu. J Transl Med 2015
Mei Ji, Yan Liu, Qing Li, Xiao-Dong Li, Wei-Qing Zhao, Hanze Zhang, Xiaofei Zhang, Jing-Ting Jiang, Chang-Ping Wu. J Transl Med 2015
50
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, Wen-Jen Hwu, Suzanne L Topalian, Patrick Hwu, Charles G Drake, Luis H Camacho, John Kauh, Kunle Odunsi,[...]. N Engl J Med 2012
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, Wen-Jen Hwu, Suzanne L Topalian, Patrick Hwu, Charles G Drake, Luis H Camacho, John Kauh, Kunle Odunsi,[...]. N Engl J Med 2012
50
The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines.
Toshifumi Doi, Takeshi Ishikawa, Tetsuya Okayama, Kaname Oka, Katsura Mizushima, Tomoyo Yasuda, Naoyuki Sakamoto, Kazuhiro Katada, Kazuhiro Kamada, Kazuhiko Uchiyama,[...]. Oncol Rep 2017
Toshifumi Doi, Takeshi Ishikawa, Tetsuya Okayama, Kaname Oka, Katsura Mizushima, Tomoyo Yasuda, Naoyuki Sakamoto, Kazuhiro Katada, Kazuhiro Kamada, Kazuhiko Uchiyama,[...]. Oncol Rep 2017
50
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.
Lieping Chen, Xue Han. J Clin Invest 2015
Lieping Chen, Xue Han. J Clin Invest 2015
50
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu,[...]. Nature 2014
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu,[...]. Nature 2014
50
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
Jun Zhou, Kathleen M Mahoney, Anita Giobbie-Hurder, Fengmin Zhao, Sandra Lee, Xiaoyun Liao, Scott Rodig, Jingjing Li, Xinqi Wu, Lisa H Butterfield,[...]. Cancer Immunol Res 2017
Jun Zhou, Kathleen M Mahoney, Anita Giobbie-Hurder, Fengmin Zhao, Sandra Lee, Xiaoyun Liao, Scott Rodig, Jingjing Li, Xinqi Wu, Lisa H Butterfield,[...]. Cancer Immunol Res 2017
50
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Roy S Herbst, Jean-Charles Soria, Marcin Kowanetz, Gregg D Fine, Omid Hamid, Michael S Gordon, Jeffery A Sosman, David F McDermott, John D Powderly, Scott N Gettinger,[...]. Nature 2014
Roy S Herbst, Jean-Charles Soria, Marcin Kowanetz, Gregg D Fine, Omid Hamid, Michael S Gordon, Jeffery A Sosman, David F McDermott, John D Powderly, Scott N Gettinger,[...]. Nature 2014
50
Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma.
Shahrzad Jalali, Tammy Price-Troska, Cole Bothun, Jose Villasboas, Hyo-Jin Kim, Zhi-Zhang Yang, Anne J Novak, Haidong Dong, Stephen M Ansell. Blood Cancer J 2019
Shahrzad Jalali, Tammy Price-Troska, Cole Bothun, Jose Villasboas, Hyo-Jin Kim, Zhi-Zhang Yang, Anne J Novak, Haidong Dong, Stephen M Ansell. Blood Cancer J 2019
50
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
50
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.